Y-Intercept (HK)’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $273K | Buy |
+12,571
| New | +$273K | 0.01% | 1384 |
|
|
2025
Q1 | – | Sell |
-27,836
| Closed | -$581K | – | 1258 |
|
|
2024
Q4 | $581K | Buy |
+27,836
| New | +$581K | 0.04% | 662 |
|
|
2024
Q3 | – | Sell |
-40,174
| Closed | -$622K | – | 1386 |
|
|
2024
Q2 | $622K | Buy |
40,174
+23,792
| +145% | +$369K | 0.03% | 725 |
|
|
2024
Q1 | $261K | Buy |
16,382
+4,820
| +42% | +$76.8K | 0.02% | 1020 |
|
|
2023
Q4 | $194K | Sell |
11,562
-46,012
| -80% | -$773K | 0.02% | 1013 |
|
|
2023
Q3 | $673K | Buy |
+57,574
| New | +$673K | 0.07% | 453 |
|
|
2022
Q3 | – | Sell |
-18,563
| Closed | -$130K | – | 1014 |
|
|
2022
Q2 | $130K | Buy |
+18,563
| New | +$130K | 0.02% | 709 |
|